RecruitingNot ApplicableNCT05719779

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Patients With Oropharyngeal Cancer: Mixed Design Study.


Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

35 participants

Start Date

Feb 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a mouth guard-like device called a mandibular advancement device (MAD) — which gently holds the jaw forward during sleep to keep the airway open — can reduce snoring and sleep apnea in patients who have been treated with radiation for oropharyngeal cancer (cancer of the throat/tonsils). Radiation can alter the throat anatomy and contribute to sleep breathing problems. **You may be eligible if...** - You have been diagnosed with oropharyngeal cancer and received radiation therapy - You are 18 or older (predominantly male patients expected) - You have complaints of snoring and/or breathing pauses during sleep **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have too few teeth remaining to support the device - You are taking opioid or anxiety medications - You have a history of major depression, uncontrolled high blood pressure, or prior stroke - You are already using a CPAP machine for sleep apnea - You have significant daily jaw or facial pain - You have excessive alcohol or drug use Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERonco-Onco and MAD

Comparison of active over a neutral mandibular advacement oral appliance to assess tolerance and efficacy in oropharyngeal cancer individuals in managing snoring and sleep apnea following radiotherapy of oropharynx.


Locations(1)

CHUM

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05719779


Related Trials